Participation in biomedical research: the consent process as viewed by children, adolescents, young adults, and

E J Susman1, L D Dorn, J C Fletcher

  • 1Laboratory of Developmental Psychology, National Institute of Mental Health, Bethesda, Maryland.

Insights

Children and young adults understand concrete research details but struggle with abstract concepts like study purpose. Age did not impact comprehension of informed consent elements in biomedical research.

Area of Science:

  • Pediatric Health
  • Bioethics
  • Clinical Research

Background:

  • Informed consent is crucial for ethical biomedical research.
  • Understanding assent and consent capacity in minors is vital.
  • Gaps in knowledge may affect participation decisions.

Purpose of the Study:

  • To assess comprehension of informed consent elements in pediatric and young adult research participants.
  • To identify what physician-investigators deem essential for these age groups to know.
  • To explore the relationship between age and knowledge of research participation.

Main Methods:

  • Structured interviews were conducted with 44 participants aged 7-20.
  • Participants were hospitalized for pediatric cancer or obesity treatment.
  • Knowledge was assessed using federal informed consent guidelines.

Main Results:

  • Participants excelled in understanding concrete elements (e.g., benefits, freedom to ask questions).
  • Comprehension of abstract elements (e.g., scientific purpose, alternatives) was lower.
  • Chronological age did not correlate with knowledge of consent elements.

Conclusions:

  • Younger populations grasp tangible aspects of research participation more readily.
  • Abstract concepts require tailored educational strategies for improved understanding.
  • Reasoning about research parallels general understanding of physical phenomena.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...